GV‐971 attenuates the progression of neuromyelitis optica in murine models and reverses alterations in gut microbiota and associated peripheral abnormalities

Documenti analoghi

• Blood‐based inflammatory protein biomarker panel for the prediction of relapse and severity in patients with neuromyelitis optica spectrum disorder: A prospective cohort study
  di: Quanfeng Wei, et al.
  Pubblicazione: (2024)
• Deciphering the intricate linkage between the gut microbiota and Alzheimer's disease: Elucidating mechanistic pathways promising therapeutic strategies
  di: Junyi Liang, et al.
  Pubblicazione: (2024)
• Efficacy of a benzothiazole‐based LRRK2 inhibitor in oligodendrocyte precursor cells and in a murine model of multiple sclerosis
  di: Rocío Benítez‐Fernández, et al.
  Pubblicazione: (2024)
• Associations between impulsivity and fecal microbiota in individuals abstaining from methamphetamine
  di: Wen Liu, et al.
  Pubblicazione: (2024)
• PV and SST neurons in the anterior cingulate cortex regulate social disorders in adulthood induced by sensory abnormalities in childhood
  di: Xiang‐Dong Wan, et al.
  Pubblicazione: (2024)